CVS Health announced profitable fourth-quarter (Q4) and full-year earnings on Wednesday (Feb. 7), crediting initiatives to improve primary care and expand omnichannel health services. These efforts aim to provide consumers with accessible care options, whether in-person, virtually or at home, the company told investors on a call. In terms of headline numbers, the Woonsocket, Rhode Island-based company reported total revenues of $358 billion in 2023, an increase of about 11% compared to the prior year, and c ...

CVS Health Corporation's (CVS) fourth-quarter 2023 adjusted earnings per share (EPS) of $2.12 rose 3.9% year over year and exceeded the Zacks Consensus Estimate by 5.5%. The adjusted EPS figure considers certain asset amortization costs, loss on assets held for sale and other adjustments.On a reported basis, the company’s GAAP earnings were $1.58 per share compared with the year-ago GAAP EPS of $1.77, down 10.7%.For the full year, adjusted earnings were $8.74 per share, down 3.2% from the year-ago period’s ...

About this content About Josh Lamb After graduating from the University of Kent in the summer of 2022 with a degree in History, Josh joined Proactive later that year as a journalist in the UK editorial team. Josh has reported on a range of areas whilst at Proactive, including energy companies during a time of global crisis, aviation and airlines as the sector recovers from the pandemic, as well as covering economic, social and governance issues. Read more About the publisher Proactive financial news and ...

CVS Health Corp (NYSE:CVS) stock is on the rise today, after better-than-expected fourth-quarter earnings of $2.12 per share and despite the healthcare giant's disappointing 2024 forecast. The company lowered its guidance as medical procedures among older patients increased, fueling costs in the insurance business. At last glance, CVS was up 2.5% at $75.63, earlier as high as $77.40 at this morning's peak. The stock is breaking above its 20-day moving average today, though its 320-day trendline appears to b ...

For the quarter ended December 2023, CVS Health (CVS) reported revenue of $93.81 billion, up 11.9% over the same period last year. EPS came in at $2.12, compared to $1.99 in the year-ago quarter.The reported revenue represents a surprise of +3.31% over the Zacks Consensus Estimate of $90.8 billion. With the consensus EPS estimate being $2.01, the EPS surprise was +5.47%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street exp ...

CVS Health reported fourth quarter 2023 net income of $2 billion thanks to double-digit percentage ... [+] growth in the company’s healthcare benefits and services businesses that included contributions from newly acquired medical providers. In this photo, a CVS Health product is displayed at a store in North Andover, Mass., Monday, May 3, 2021. (AP Photo/Elise Amendola, File)Copyright 2021 The Associated Press. All rights reserved.CVS Health reported net income of $2 billion thanks to double-digit percenta ...

Shares of CVS Health Corp. CVS, +1.82% fell 0.3% in premarket trading Wednesday, after the drugstore chain and health care services company’s fourth-quarter results beat expectations by wide margins, but lowered its full-year outlook because of “elevated medical cost trends.” Net income fell to $2.05 billion, or $1.58 a share, from $2.33 billion, or $1.77 a share, in the year-ago period. Excluding nonrecurring items, adjusted earnings per share of $2.12 beat the FactSet consensus of $1.98. Revenue grew 11. ...

CVS Health on Wednesday reported fourth-quarter revenue and adjusted earnings that topped expectations, but the company cut its full-year profit outlook, citing higher medical costs that are dogging the broader insurance industry.The company lowered its 2024 adjusted earnings forecast to at least $8.30 per share, down from a previous guidance of at least $8.50 per share. Analysts surveyed by LSEG were expecting full-year adjusted earnings of $8.49 per share. CVS also cut its unadjusted earnings guidance to ...

Since betting on the individual companies of the Standard and Poor’s 500 offers a solid chance for long-term profitability, it stands to reason that going for undervalued S&P 500 stocks could potentially net you robust returns. In a way, it’s like having your cake and eating it too.For as long as I can remember, sports fans have long wondered what would happen if the weakest team in the NFL went head-to-head with the strongest team in college football. Chances are, the pro team should run circles around the ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to_________ Commission file number: 001-01011 CVS HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 05-0494040 (State or ...